|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
We Burn Fat: UltraShape Ltd. CEO Rodger Stewart on the FDA, an IPO, and Fat
8/24/2007 8:29:44 AM
"When I met Ultrashape it was not love at first sight. I didn't know a lot about medical progress in Israel, and I had no experience of the market, but the basic criterion fitted, and love followed soon after. I've had experience with a number of cultures, especially Italian and Swedish, and when they told me that Israelis are very direct, I liked it. It's the exact opposite of the Italians," says Rodger Stewart, the fairly new CEO at aesthetic medical device company UltraShape Ltd. (since January 2007), surprisingly. Stewart is a former engineer who began working at medical device companies and subsequently found himself drawn into marketing and business development roles. He previously served as president and CEO of COBE Cardiovascular, Inc. which reached almost $200 million sales and was later acquired by Italy's Sorin Group.
|
|
|
|
|
|
|
|
|
|
|